Beam Therapeutics Inc
NASDAQ:BEAM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Beam Therapeutics Inc
NASDAQ:BEAM
|
US |
|
Siti Networks Ltd
NSE:SITINET
|
IN |
|
D
|
DoorDash Inc
F:DD2
|
US |
|
Mcphy Energy SA
PAR:MCPHY
|
FR |
|
Subsea 7 SA
OTC:SUBCY
|
UK |
|
C
|
Card Factory PLC
OTC:CRFCF
|
UK |
|
SS Lazio SpA
MIL:SSL
|
IT |
|
Stitch Fix Inc
NASDAQ:SFIX
|
US |
|
G
|
Growthpoint Properties Ltd
JSE:GRT
|
ZA |
|
H
|
Henry Schein Inc
XMUN:HS2
|
US |
|
Baidu Inc
NASDAQ:BIDU
|
CN |
|
Skechers USA Inc
NYSE:SKX
|
US |
|
G
|
Gazprom Neft' PAO
LSE:GAZ
|
RU |
|
P
|
Prologis Inc
LSE:0KOD
|
US |
|
Societe BIC SA
PAR:BB
|
FR |
|
C
|
Colbun SA
SGO:COLBUN
|
CL |
|
N
|
Nintendo Co Ltd
F:NTO
|
JP |
|
G
|
Goodfellow Inc
OTC:GFELF
|
CA |
|
TOMI Environmental Solutions Inc
NASDAQ:TOMZ
|
US |
|
C
|
Citra Tubindo Tbk PT
IDX:CTBN
|
ID |
|
J
|
Julius Baer Gruppe AG
SIX:BAERE
|
CH |
|
BKW AG
SIX:BKW
|
CH |
|
T
|
Tencent Holdings Ltd
OTC:TCEHY
|
CN |
|
B
|
BTS Group Holdings PCL
SET:BTS
|
TH |
Bankruptcy Probability
Beam Therapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Beam Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Beam Therapeutics Inc
NASDAQ:BEAM
|
3.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
384.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
181.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
167B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
113.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
65B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
44.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
40.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Beam Therapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Beam Therapeutics Inc has total debt of 100.2m USD. This includes both short-term (0 USD) and long-term (100.2m USD) debt.
You can find a full breakdown on its Balance Sheet.
